newsfilter
← Latest News
PR Newswire·

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

  • China SXT Pharmaceuticals, Inc. announced a 1-for-100 share consolidation of its Class A ordinary shares.
  • The consolidation becomes effective on October 26, 2026, with post-consolidation trading beginning at the market open that day.
  • Shares will continue trading on Nasdaq under the symbol "SXTC" with a new CUSIP number G2161P181.
  • Pre-consolidation outstanding shares total 68,677,500 (68,677,498 Class A shares & 2 Class B shares).
  • Post-consolidation outstanding shares are expected to be approximately 686,775 Class A shares & 2 Class B shares.
  • Fractional Class A shares will be rounded up to the next whole share, while Class B shares remain unaffected.
  • All outstanding stock options, warrants, & purchase rights for Class A shares will be adjusted proportionately.
  • Shareholders holding shares through nominees will have their holdings automatically adjusted.
  • Questions can be directed to the Company's transfer agent, Transhare Corporation, at +1 303-662-1122.
  • The Company is an innovative pharmaceutical firm founded in 2005, focusing on processed Traditional Chinese Medicine pieces.